Step 1

It starts with a trip
to your doctor

to see if EVO ICL (EVO) is right for you.

Step 2

Precise
measurement

Your eyes are examined and precisely measured by your doctor to ensure each EVO lens is suited to your eye's personal characteristics.

Step 3

Ordering
the lenses

The doctor uses EVO lens software to assist in calculating, selecting, and ordering the proper customized lens.

Step 4

Button
of Collamer®

a soft, flexible and biocompatible material, unique to STAAR, is selected for you.

Step 5

Shaping
the lens

Next, it’s made into the shape of the EVO lens.

Step 6

Precision
milling arm

A precision milling arm is used to cut each lens to its exact specifications.

Step 7

Handcrafted
and polished

Then it is handcrafted and polished, tumbled and hydrated until it is exactly right.

Step 8

Rigorous testing
and inspection

Finally, each EVO lens undergoes rigorous testing and inspection to meet our premium standards.

Step 9

Delivery
to the doctor

The lenses are delivered to the doctor who has ordered them.

Step 10

Implantation
of the lens

The personalized EVO lenses are implanted by your doctor.

Step 11

EVO ICL

An evolution
in visual freedom

ICLs have been around for over 20 years and over 2 million lenses have been distributed worldwide. 99.4% of patients surveyed said they would have the procedure again.¹

Jj testimonial page mobile

Joe Jonas

Joe Jonas dreamed of a day where he could live life uninhibited by his nearsightedness. Joe had the EVO procedure to correct his distance vision. See his story on how he broke free from the hassles of contacts and glasses.

Important Safety Information

EVO & EVO TICL is designed for the correction of moderate to high near-sightedness (-0.5 to -20.0 dioptres (D)) and the reduction of near-sightedness in patients with up to -20 dioptres (D) of near-sightedness with less than or equal to 6.0 dioptres (D) of astigmatism. It is indicated for patients who are 21 to 45 years of age. In order to be sure that your surgeon will use a EVO with the most adequate power for your eye, your near-sightedness should be stable for at least a year before undergoing eye surgery. EVO surgery has been documented to safely and effectively correct near-sightedness between -0.5 dioptres (D) to -20.0 dioptres (D) and partially correct near-sightedness up to -20 dioptres in eyes with up to 6.0(D) of astigmatism. If you have near-sightedness within these ranges, EVO surgery may improve your distance vision without eyeglasses or contact lenses. EVO surgery does not eliminate the need for reading glasses, even if you have never worn them before. The EVO represents an alternative to other refractive surgeries including, laser assisted in situ keratomileusis (LASIK), photorefractive keratectomy (PRK), incisional surgeries, or other means to correct myopia such as contact lenses and eye glasses. EVO is not intended to correct any astigmatism you may have. Implantation of the EVO is a surgical procedure, and as such, carries potentially serious risks. Please discuss the risks with your eye care provider. The following represent potential complications/adverse events reported in conjunction with refractive surgery in general: conjunctival irritation, acute corneal swelling, persistent corneal swelling, endophthalmitis (total eye infection), significant glare and/or halos around lights, hyphaema (blood in the eye), hypopyon (pus in the eye), eye infection, EVO ICL dislocation, macular oedema, non-reactive pupil, pupillary block glaucoma, severe inflammation of the eye, iritis, uveitis, vitreous loss and corneal transplant. Before considering EVO surgery you should have a complete eye examination and talk with your eye care professional about EVO surgery, especially the potential benefits, risks and complications. You should discuss the time needed for healing after surgery.

संदर्भ

1Visian ICL Patient Information Booklet

2Sanders D. Vukich JA. Comparison of implantable collamer lens (ICL) and laser-assisted in situ keratomileusis (LASIK) for Low Myopia. Cornea. 2006 Dec; 25(10):1139-46.

3Naves, J.S. Carracedo, G. Cacho-Babillo, I. Diadenosine Nucleotid Measurements as Dry-Eye Score in Patients After LASIK and ICL Surgery. Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2012.

4Shoja, MR. Besharati, MR. Dry eye after LASIK for myopia: Incidence and risk factors. European Journal of Ophthalmology. 2007; 17(1): pp. 1-6.

5aLee, Jae Bum et al. Comparison of tear secretion and tear film instability after photorefractive keratectomy and laser in situ keratomileusis. Journal of Cataract & Refractive Surgery , Volume 26 , Issue 9 , 1326 - 1331.

5bParkhurst, G. Psolka, M. Kezirian, G. Phakic intraocular lens implantantion in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481.

*American Refractive Surgery Council